ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JONATHAN PETERSON M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1300

$13.5K Total Retail Price of All Prescriptions

Rank: 1291 out of 1300

432 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

21% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 28,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

77 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LISINOPRIL 1,562 1,338 1 2
FUROSEMIDE 1,385 1,226 2 8
LEVOTHYROXINE SODIUM 1,333 1,228 3 1
OMEPRAZOLE 1,183 1,013 4 4
ATORVASTATIN CALCIUM 1,011 738 5 13
SIMVASTATIN 941 871 6 3
POTASSIUM CHLORIDE 929 772 7 18
LOSARTAN POTASSIUM 819 749 8 16
METOPROLOL SUCCINATE 713 613 9 24
METOPROLOL TARTRATE 676 629 10 11
CITALOPRAM HBR 663 533 11 19
METFORMIN HCL 648 542 12 7
WARFARIN SODIUM 628 604 13 9
HYDROCODONE-ACETAMINOPHEN 624 535 S3 14 5
AMLODIPINE BESYLATE 597 549 15 6
GABAPENTIN 537 444 16 15
FELODIPINE ER 527 420 10 17 115
ATENOLOL 503 435 18 12
HYDROCHLOROTHIAZIDE 477 347 19 10
PANTOPRAZOLE SODIUM 459 421 20 36
TRAZODONE HCL 458 428 21 34
RANITIDINE HCL 419 320 22 27
DONEPEZIL HCL 377 374 23 32
TRAMADOL HCL 369 347 24 17
ALENDRONATE SODIUM 346 223 25 20
TAMSULOSIN HCL 327 316 26 25
OXYCODONE-ACETAMINOPHEN 320 214 S2 27 28
HYDRALAZINE HCL 299 299 28 133
CARVEDILOL 280 274 29 38
NAMENDA 266 261 30 51
ALLOPURINOL 266 265 30 29
DOXAZOSIN MESYLATE 264 202 32 71
ISOSORBIDE MONONITRATE ER 264 257 32 82
LYRICA 257 217 34 75
DIOVAN 228 184 35 66
GLIPIZIDE 221 170 36 33
OXYCODONE HCL 216 192 S2 37 35
ZOLPIDEM TARTRATE 213 80 38 14
CLOPIDOGREL 194 146 39 64
SPIRONOLACTONE 193 184 40 55
PRAVASTATIN SODIUM 192 192 41 23
GLIPIZIDE XL 191 153 42 142
OXYCONTIN 175 108 S2 43 70
PHENYTOIN SODIUM EXTENDED 175 163 43 118
LANTUS 171 149 45 43
VENLAFAXINE HCL ER 170 113 46 69
FINASTERIDE 166 166 47 80
PRADAXA 164 143 48 113
NIFEDIPINE ER 160 160 49 191
ADVAIR DISKUS 159 158 50 41
MIRTAZAPINE 158 87 51 50
LEVETIRACETAM 153 116 52 107
TROSPIUM CHLORIDE 153 152 52 91
LIDODERM 147 143 54 74
CYMBALTA 143 77 55 44
GLIPIZIDE ER 142 142 56 99
LOVASTATIN 136 111 57 22
ESCITALOPRAM OXALATE 134 130 58 84
MORPHINE SULFATE ER 131 66 S2 59 49
VENTOLIN HFA 128 104 60 109
COMBIVENT 124 94 61 138
ROPINIROLE HCL 123 123 62 106
POLYETHYLENE GLYCOL 3350 122 116 63 65
QUETIAPINE FUMARATE 119 74 64 57
METHYLPHENIDATE HCL 115 0 65 198
SPIRIVA 111 108 66 45
LABETALOL HCL 111 94 66 187
NORTRIPTYLINE HCL 110 110 68 110
DILTIAZEM 24HR CD 109 71 69 139
CALCIUM ACETATE 106 53 70 200
CARBIDOPA-LEVODOPA 103 103 71 68
PROPRANOLOL HCL 103 103 71 116
PLAVIX 102 94 73 112
DILTIAZEM 24HR ER 101 101 74 272
LUNESTA 101 92 74 228
PAROXETINE HCL 101 96 74 59
THEOPHYLLINE ANHYDROUS 100 100 77 274
SERTRALINE HCL 98 98 78 26
DIGOXIN 98 98 78 48
CLONIDINE HCL 92 40 80 102
PREDNISONE 90 78 81 40
FLUTICASONE PROPIONATE 89 73 82 30
RISPERIDONE 88 78 83 77
CELEBREX 88 84 83 95
LATANOPROST 88 87 83 152
DILTIAZEM ER 88 36 83 154
LUMIGAN 78 76 87 291
FLUOXETINE HCL 77 72 88 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 75 88 128
ABILIFY 77 0 88 129
CALCITRIOL 76 35 91 218
AVODART 76 76 91 293
GALANTAMINE HBR 75 75 93 245
FAMOTIDINE 72 68 94 73
VENLAFAXINE HCL 69 64 95 152
ENALAPRIL MALEATE 66 66 96 93
NOVOLIN 70-30 65 64 97 155
DEXAMETHASONE 64 64 98 249
CIPROFLOXACIN HCL 62 58 99 87
PRIMIDONE 60 60 100 260
ESTROPIPATE 59 59 R 101 314
IPRATROPIUM-ALBUTEROL 59 59 101 127
XIFAXAN 57 0 103 318
RENVELA 56 17 104 321
METOCLOPRAMIDE HCL 56 0 104 143
ONDANSETRON HCL 54 49 106 232
MORPHINE SULFATE 54 46 S2 106 157
ANASTROZOLE 53 0 108 248
ACYCLOVIR 53 53 108 332
MINOXIDIL 52 43 110 339
DETROL LA 52 52 110 189
NOVOLIN R 51 51 112 211
TAMOXIFEN CITRATE 51 51 112 271
OLANZAPINE 51 50 112 86
SINGULAIR 51 51 112 179
CARBAMAZEPINE 51 51 112 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.